Sienna Biopharmaceuticals CFO John Smither's 2018 pay jumps 1,541% to $2.7M
Sienna Biopharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 11, 2019
Sienna Biopharmaceuticals reported fiscal year 2018 executive compensation information on April 11, 2019.
In 2018, three executives at Sienna Biopharmaceuticals received on average a compensation package of $2.1M, a 105% increase compared to previous year.
Average pay of disclosed executives at Sienna Biopharmaceuticals
John W. Smither, Chief Financial Officer, received $2.7M in total, which increased by 1,541% compared to 2017. 87% of Smither's compensation, or $2.3M, was in option awards. Smither also received $89K in non-equity incentive plan and $255K in salary.
Frederick C. Beddingfield III, Chief Executive Officer, received a compensation package of $2.6M, which increased by 11% compared to previous year. 71% of the compensation package, or $1.9M, was in option awards.
Timothy K. Andrews, General Counsel, earned $1M in 2018, a 129% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 11, 2019.